Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.

Lazzaroni MG, Fredi M, Andreoli L, Chighizola CB, Del Ross T, Gerosa M, Kuzenko A, Raimondo MG, Lojacono A, Ramazzotto F, Zatti S, Trespidi L, Meroni PL, Pengo V, Ruffatti A, Tincani A.

Front Immunol. 2019 Aug 14;10:1948. doi: 10.3389/fimmu.2019.01948. eCollection 2019.

2.

Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.

Cavazzana I, Richards M, Bentow C, Seaman A, Fredi M, Giudizi MG, Palterer B, Pratesi F, Migliorini P, Franceschini F, Satoh M, Ceribelli A, Mahler M.

J Immunol Methods. 2019 Nov;474:112661. doi: 10.1016/j.jim.2019.112661. Epub 2019 Aug 21.

3.

Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?

Cavazzana I, Fredi M, Franceschini F.

Ann Rheum Dis. 2019 Jul 15. pii: annrheumdis-2019-215884. doi: 10.1136/annrheumdis-2019-215884. [Epub ahead of print] No abstract available.

PMID:
31308068
4.

Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.

Cavazzana I, Kumar R, Pozzari C, Ottaviani R, Fredi M, Piantoni S, Andreoli L, Tincani A, Franceschini F.

Lupus. 2019 Aug;28(9):1074-1081. doi: 10.1177/0961203319860191. Epub 2019 Jul 11.

PMID:
31296140
5.

Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis.

Bruschi M, Bonanni A, Petretto A, Vaglio A, Pratesi F, Santucci L, Migliorini P, Bertelli R, Galetti M, Belletti S, Cavagna L, Moroni G, Franceschini F, Fredi M, Pazzola G, Allegri L, Sinico RA, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Ramoino P, Bianchini P, Puppo F, Pupo F, Negrini S, Mattana F, Emmi G, Garibotto G, Santoro D, Scolari F, Ravelli A, Tincani A, Cravedi P, Volpi S, Candiano G, Ghiggeri GM.

J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232. [Epub ahead of print]

PMID:
31092713
6.

Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.

Bartoloni E, Bistoni O, Alunno A, Cavagna L, Nalotto L, Baldini C, Priori R, Fischetti C, Fredi M, Quartuccio L, Carubbi F, Montecucco C, Doria A, Mosca M, Valesini G, Franceschini F, De Vita S, Giacomelli R, Mirabelli G, Bini V, Gabrielli A, Catassi C, Gerli R.

J Clin Med. 2019 Apr 19;8(4). pii: E540. doi: 10.3390/jcm8040540.

7.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

8.

C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.

Fredi M, Cavazzana I, Biasiotto G, Filosto M, Padovani A, Monti E, Tincani A, Franceschini F, Zanella I.

Neuromolecular Med. 2019 Jun;21(2):150-159. doi: 10.1007/s12017-019-08528-8. Epub 2019 Mar 11.

PMID:
30859373
9.

Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors.

Cavazzana I, Piantoni S, Sciatti E, Fredi M, Taraborelli M, Bonadei I, Airò P, Metra M, Tincani A, Franceschini F, Vizzardi E.

Lupus. 2019 Feb;28(2):210-216. doi: 10.1177/0961203318821161. Epub 2019 Jan 4.

PMID:
30608206
10.

Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis.

Galli J, Gavazzi F, De Simone M, Giliani S, Garau J, Valente M, Vairo D, Cattalini M, Mortilla M, Andreoli L, Badolato R, Bianchi M, Carabellese N, Cereda C, Ferraro R, Facchetti F, Fredi M, Gualdi G, Lorenzi L, Meini A, Orcesi S, Tincani A, Zanola A, Rice G, Fazzi E; AGS study group.

Medicine (Baltimore). 2018 Dec;97(52):e13893. doi: 10.1097/MD.0000000000013893.

11.

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies.

Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D'Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A.

Autoimmun Rev. 2019 Feb;18(2):164-176. doi: 10.1016/j.autrev.2018.08.008. Epub 2018 Dec 18. Review.

PMID:
30572134
12.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

13.

Systemic Lupus Erythematosus and Endothelial Dysfunction: A Close Relationship.

Sciatti E, Cavazzana I, Vizzardi E, Bonadei I, Fredi M, Taraborelli M, Ferizi R, Metra M, Tincani A, Franceschini F.

Curr Rheumatol Rev. 2019;15(3):177-188. doi: 10.2174/1573397115666181126105318.

PMID:
30474532
14.

Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women.

Belhocine M, Coutte L, Martin Silva N, Morel N, Guettrot-Imbert G, Paule R, Le Jeunne C, Fredi M, Dreyfus M, Piette JC, Souchaud-Debouverie O, Deneux-Tharaux C, Tsatsaris V, Pannier E, Le Guern V, Costedoat-Chalumeau N.

Arthritis Res Ther. 2018 Nov 6;20(1):249. doi: 10.1186/s13075-018-1745-2.

15.

Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease.

Tamanini S, Fredi M, Crisafulli F, Lazzaroni MG, Tincani A, Franceschini F.

Clin Rheumatol. 2019 Feb;38(2):609-610. doi: 10.1007/s10067-018-4357-y. Epub 2018 Nov 5. No abstract available.

PMID:
30397839
16.

The clinico-serological spectrum of overlap myositis.

Fredi M, Cavazzana I, Franceschini F.

Curr Opin Rheumatol. 2018 Nov;30(6):637-643. doi: 10.1097/BOR.0000000000000536. Review.

PMID:
30074509
17.

Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.

Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, Mouthon L, le Jeunne C, Chauvin A, Piette JC, Costedoat-Chalumeau N.

Autoimmun Rev. 2018 Sep;17(9):866-872. doi: 10.1016/j.autrev.2018.03.011. Epub 2018 Jul 10. Review.

PMID:
30005859
18.

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.

Dall'Ara F, Cavazzana I, Frassi M, Taraborelli M, Fredi M, Franceschini F, Andreoli L, Rossi M, Cattaneo C, Tincani A, Airò P.

Reumatismo. 2018 Jul 6;70(2):100-105. doi: 10.4081/reumatismo.2018.1023.

19.

Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.

Fredi M, Andreoli L, Aggogeri E, Bettiga E, Lazzaroni MG, Le Guern V, Lojacono A, Morel N, Piette JC, Zatti S, Costedoat-Chalumeau N, Tincani A.

Front Immunol. 2018 May 7;9:864. doi: 10.3389/fimmu.2018.00864. eCollection 2018.

20.

Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset.

Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Tincani A, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.

Lupus. 2018 Aug;27(9):1479-1488. doi: 10.1177/0961203318777112. Epub 2018 May 19.

PMID:
29779436
21.

Endothelial Dysfunction in Early Systemic Lupus Erythematosus Patients and Controls Without Previous Cardiovascular Events.

Taraborelli M, Sciatti E, Bonadei I, Terlizzi V, Fredi M, Zani R, Cancarini G, Tincani A, Franceschini F, Vizzardi E, Cavazzana I.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1277-1283. doi: 10.1002/acr.23495. Epub 2018 Aug 16.

22.

Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study.

John G, Avouac J, Piantoni S, Polito P, Fredi M, Cozzi F, Airò P, Truchetet ME, Franceschini F, Allanore Y, Chizzolini C.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1218-1227. doi: 10.1002/acr.23454. Epub 2018 Jun 19.

23.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

24.

The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study.

John G, Allanore Y, Polito P, Piantoni S, Fredi M, Avouac J, Franceschini F, Truchetet ME, Cozzi F, Airo P, Chizzolini C.

Rheumatology (Oxford). 2017 Nov 1;56(11):1874-1883. doi: 10.1093/rheumatology/kex230.

PMID:
28977630
25.

Should we treat congenital heart block with fluorinated corticosteroids?

Brucato A, Tincani A, Fredi M, Breda S, Ramoni V, Morel N, Costedoat-Chalumeau N.

Autoimmun Rev. 2017 Nov;16(11):1115-1118. doi: 10.1016/j.autrev.2017.09.005. Epub 2017 Sep 9. Review. No abstract available.

PMID:
28899797
26.

Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.

Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A.

J Rheumatol. 2017 Aug;44(8):1165-1172. doi: 10.3899/jrheum.161364. Epub 2017 Jun 1.

PMID:
28572466
27.

Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies.

Fredi M, Cavazzana I, Zanola A, Carabellese N, Tincani A, Mahler M, Franceschini F.

Lupus. 2017 Sep;26(10):1121-1122. doi: 10.1177/0961203317696592. Epub 2017 Mar 10. No abstract available.

PMID:
28420064
28.

Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.

Taraborelli M, Cavazzana I, Martinazzi N, Lazzaroni MG, Fredi M, Andreoli L, Franceschini F, Tincani A.

Lupus. 2017 Oct;26(11):1197-1204. doi: 10.1177/0961203317693096. Epub 2017 Feb 22.

PMID:
28420047
29.

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.

Taraborelli M, Lazzaroni MG, Martinazzi N, Fredi M, Cavazzana I, Franceschini F, Tincani A.

Reumatismo. 2016 Dec 16;68(3):137-143. doi: 10.4081/reumatismo.2016.891.

30.

Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.

Fredi M, Bartoli F, Cavazzana I, Ceribelli A, Carabellese N, Tincani A, Satoh M, Franceschini F.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):303-308. Epub 2016 Nov 14.

31.

A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus.

Lazzaroni MG, Dall'Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A.

J Autoimmun. 2016 Nov;74:106-117. doi: 10.1016/j.jaut.2016.06.016. Epub 2016 Jul 2. Review.

PMID:
27377453
32.

Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.

Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C.

Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20.

33.

Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi-Goutières Syndrome.

Cattalini M, Galli J, Andreoli L, Olivieri I, Ariaudo G, Fredi M; IAGSA study group, Orcesi S, Tincani A, Fazzi E.

J Clin Immunol. 2016 Oct;36(7):693-9. doi: 10.1007/s10875-016-0325-y. Epub 2016 Aug 18.

PMID:
27539236
34.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
35.

Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort.

Alijotas-Reig J, Ferrer-Oliveras R, Esteve-Valverde E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, Coloma E, de Carolis S, Rovere-Querini P, Canti V, Picardo E, Fredi M, Mekinian A; EUROAPS Study Group.

Am J Reprod Immunol. 2016 Aug;76(2):164-71. doi: 10.1111/aji.12534.

PMID:
27401589
36.

Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.

Iaccarino L, Bettio S, Reggia R, Zen M, Frassi M, Andreoli L, Gatto M, Piantoni S, Nalotto L, Franceschini F, Larosa M, Fredi M, Punzi L, Tincani A, Doria A.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):115-123. doi: 10.1002/acr.22971. Epub 2016 Nov 18.

37.

Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.

Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, Tincani A, Satoh M, Franceschini F.

J Immunol Methods. 2016 Jun;433:1-5. doi: 10.1016/j.jim.2016.02.017. Epub 2016 Feb 18.

PMID:
26906088
38.

The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Cavazzana I, Fredi M, Selmi C, Tincani A, Franceschini F.

Clin Rev Allergy Immunol. 2017 Feb;52(1):88-98. doi: 10.1007/s12016-015-8517-4. Review.

PMID:
26514357
39.

Typing TREX1 gene in patients with systemic lupus erythematosus.

Fredi M, Bianchi M, Andreoli L, Greco G, Olivieri I, Orcesi S, Fazzi E, Cereda C, Tincani A.

Reumatismo. 2015 Jun 30;67(1):1-7. doi: 10.4081/reumatismo.2015.782.

40.

Myositis autoantibodies and clinical phenotypes.

Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A.

Auto Immun Highlights. 2014 Aug 23;5(3):69-75. doi: 10.1007/s13317-014-0060-4. eCollection 2014 Dec. Review.

41.

Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies.

Fredi M, Lazzaroni MG, Tani C, Ramoni V, Gerosa M, Inverardi F, Sfriso P, Caramaschi P, Andreoli L, Sinico RA, Motta M, Lojacono A, Trespidi L, Strigini F, Brucato A, Caporali R, Doria A, Guillevin L, Meroni PL, Montecucco C, Mosca M, Tincani A.

Autoimmun Rev. 2015 Aug;14(8):686-91. doi: 10.1016/j.autrev.2015.03.009. Epub 2015 Apr 7. Review.

PMID:
25858351
42.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.

Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators).

Autoimmun Rev. 2015 May;14(5):387-95. doi: 10.1016/j.autrev.2014.12.010. Epub 2014 Dec 31. Review.

PMID:
25555817
43.

Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis.

Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):732-4. Epub 2014 Sep 8.

PMID:
25198168
44.

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.

Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C, Chan JY, Chan EK, Satoh M, Franceschini F.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):891-7. Epub 2014 Aug 15.

PMID:
25151986
45.

Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.

Taraborelli M, Cavazzana I, Fredi M, Airò P, Nascimbeni G, Tincani A, Franceschini F.

Clin Rheumatol. 2015 Apr;34(4):791-4. doi: 10.1007/s10067-014-2694-z. Epub 2014 Jun 11.

PMID:
25028250
46.

Rare autoantibodies to cellular antigens in systemic lupus erythematosus.

Fredi M, Cavazzana I, Quinzanini M, Taraborelli M, Cartella S, Tincani A, Franceschini F.

Lupus. 2014 Jun;23(7):672-7. doi: 10.1177/0961203314524850. Epub 2014 Feb 20.

PMID:
24557777
47.

A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.

Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):118-21. Epub 2013 Jul 23.

PMID:
23910615
48.

Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies.

Andreoli L, Fredi M, Nalli C, Piantoni S, Reggia R, Dall'Ara F, Franceschini F, Tincani A.

Curr Rheumatol Rep. 2013 Jul;15(7):343. doi: 10.1007/s11926-013-0343-1. Review.

PMID:
23754504
49.

Antiphospholipid antibodies mediate autoimmunity against dying cells.

Andreoli L, Fredi M, Nalli C, Franceschini F, Meroni PL, Tincani A.

Autoimmunity. 2013 Aug;46(5):302-6. doi: 10.3109/08916934.2013.783025. Epub 2013 May 29. Review.

PMID:
23713583
50.

Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients.

Gatta D, Fredi M, Aliprandi G, Pini L, Tantucci C.

Int J Chron Obstruct Pulmon Dis. 2013;8:169-73. doi: 10.2147/COPD.S38320. Epub 2013 Mar 28.

Supplemental Content

Support Center